Could low FSH indicate a problem with my pituitary gland?

Low FSH levels can indicate pituitary dysfunction, but other causes like hormonal suppression, medications, or stress are also possible. A comprehensive hormone panel including LH, testosterone/estrogen, and prolactin helps determine if the pituitary is the underlying issue.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding FSH and Its Role in Your Body

Follicle-stimulating hormone (FSH) is a crucial reproductive hormone produced by your pituitary gland, a pea-sized organ located at the base of your brain. This hormone plays different but equally important roles in both men and women. In women, FSH stimulates the growth of ovarian follicles and helps regulate the menstrual cycle. In men, it's essential for sperm production and maintaining healthy testosterone levels.

The pituitary gland acts as your body's master hormone regulator, receiving signals from the hypothalamus and responding by releasing various hormones, including FSH. When FSH levels drop below normal ranges, it can signal several potential issues, with pituitary dysfunction being one important possibility to investigate.

What Are Normal FSH Levels?

FSH levels vary significantly based on age, sex, and for women, the phase of their menstrual cycle. Understanding these normal ranges helps contextualize whether your levels are truly low.

Normal FSH Ranges by Population

Values below these ranges may indicate hypogonadotropic hypogonadism or pituitary dysfunction
PopulationFSH Range (mIU/mL)Clinical Notes
MenAdult Men1.5-12.4Remains relatively stable throughout adult life
Women - FollicularWomen - Follicular Phase1.4-9.9Days 1-14 of menstrual cycle
Women - OvulationWomen - Ovulation6.2-17.2Mid-cycle peak, typically day 14
Women - LutealWomen - Luteal Phase1.1-9.2Post-ovulation until menstruation
Women - PostmenopausalWomen - Postmenopausal19.3-100.6Elevated due to loss of negative feedback

Values below these ranges may indicate hypogonadotropic hypogonadism or pituitary dysfunction

For men, normal FSH levels typically range from 1.5 to 12.4 mIU/mL throughout adult life. Women's levels fluctuate more dramatically: during the follicular phase (1.4-9.9 mIU/mL), ovulation (6.2-17.2 mIU/mL), luteal phase (1.1-9.2 mIU/mL), and post-menopause (19.3-100.6 mIU/mL). Values below these ranges may be considered low and warrant further investigation.

How the Pituitary Gland Controls FSH Production

Your pituitary gland operates within a complex feedback system called the hypothalamic-pituitary-gonadal (HPG) axis. The hypothalamus releases gonadotropin-releasing hormone (GnRH), which signals the pituitary to produce both FSH and luteinizing hormone (LH). These hormones then stimulate the gonads (ovaries or testes) to produce sex hormones and gametes.

When this system functions properly, hormone levels self-regulate through negative feedback. High levels of sex hormones signal the pituitary to reduce FSH production, while low sex hormone levels trigger increased FSH release. However, when the pituitary gland itself has problems, this delicate balance can be disrupted, potentially leading to inappropriately low FSH levels despite the body's need for more.

Pituitary Causes of Low FSH

Hypopituitarism

Hypopituitarism occurs when the pituitary gland fails to produce adequate amounts of one or more hormones. This condition can affect FSH production along with other pituitary hormones like growth hormone, ACTH, and TSH. Causes include pituitary tumors, head trauma, radiation therapy, infections, or genetic conditions. When hypopituitarism affects FSH and LH production specifically, it's called hypogonadotropic hypogonadism.

Pituitary Tumors

Both functioning and non-functioning pituitary adenomas can cause low FSH. Prolactinomas, the most common type of functioning pituitary tumor, produce excess prolactin which suppresses GnRH and subsequently FSH production. Non-functioning tumors can compress normal pituitary tissue, physically impairing hormone production. Even small microadenomas (less than 10mm) can significantly impact hormone levels.

Other Pituitary Conditions

Several other pituitary conditions can lead to low FSH levels. Sheehan's syndrome, caused by severe blood loss during childbirth, damages the pituitary gland. Empty sella syndrome, where cerebrospinal fluid fills the space around the pituitary, can compress the gland. Hemochromatosis (iron overload) and infiltrative diseases like sarcoidosis can also damage pituitary tissue and impair FSH production.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Non-Pituitary Causes of Low FSH

While pituitary problems are an important consideration, many cases of low FSH stem from other causes. Understanding these alternatives helps ensure accurate diagnosis and appropriate treatment. Regular monitoring through comprehensive hormone testing can help identify the true underlying cause.

Hormonal Suppression

External hormone use is a common cause of suppressed FSH. In men, testosterone replacement therapy or anabolic steroid use signals the pituitary to reduce FSH and LH production. Women taking hormonal contraceptives experience similar suppression. This effect is usually reversible once the external hormones are discontinued, though recovery time varies.

Lifestyle and Environmental Factors

  • Extreme weight loss or eating disorders can suppress the HPG axis
  • Intense exercise, particularly in female athletes, may cause functional hypothalamic amenorrhea
  • Chronic stress elevates cortisol, which can inhibit GnRH and FSH release
  • Certain medications including opioids, glucocorticoids, and some psychiatric drugs
  • Obesity can alter hormone metabolism and feedback mechanisms

Medical Conditions

Several medical conditions outside the pituitary can cause low FSH. Kallmann syndrome, a genetic condition, affects GnRH neurons in the hypothalamus. Chronic illnesses like kidney disease, liver disease, or uncontrolled diabetes can suppress reproductive hormones. Hyperprolactinemia from non-pituitary causes (medications, hypothyroidism) also inhibits FSH production.

Symptoms Associated with Low FSH

Low FSH often presents with symptoms related to reduced sex hormone production, though the specific manifestations differ between men and women. Recognizing these symptoms can prompt timely testing and diagnosis.

In women, symptoms include irregular or absent periods, difficulty conceiving, hot flashes, vaginal dryness, and decreased libido. Men may experience reduced sperm count, erectile dysfunction, decreased muscle mass, fatigue, and mood changes. Both sexes can experience bone density loss, as sex hormones play crucial roles in maintaining bone health.

Diagnostic Tests for Low FSH and Pituitary Function

Diagnosing the cause of low FSH requires a comprehensive approach. Initial testing should include not just FSH, but also LH, sex hormones (testosterone in men, estradiol in women), and prolactin. This panel helps distinguish between primary gonadal failure and central (hypothalamic-pituitary) causes.

Blood Tests

  • FSH and LH levels (both typically low in pituitary dysfunction)
  • Total and free testosterone (men) or estradiol (women)
  • Prolactin (elevated levels suggest prolactinoma)
  • Other pituitary hormones: TSH, free T4, ACTH, cortisol, IGF-1
  • Complete blood count and metabolic panel to rule out systemic illness

Imaging Studies

If blood tests suggest pituitary dysfunction, magnetic resonance imaging (MRI) of the pituitary gland is typically the next step. MRI can detect tumors, empty sella syndrome, or other structural abnormalities. In some cases, computed tomography (CT) may be used if MRI is contraindicated.

Dynamic Testing

Sometimes, stimulation tests help assess pituitary reserve. The GnRH stimulation test evaluates the pituitary's ability to produce FSH and LH in response to synthetic GnRH. The insulin tolerance test or glucagon stimulation test can assess overall pituitary function, particularly growth hormone and ACTH reserve.

Treatment Options for Low FSH

Treatment for low FSH depends entirely on the underlying cause. When pituitary dysfunction is confirmed, treatment may involve hormone replacement therapy, addressing any pituitary tumors, or managing the underlying condition affecting the gland.

Hormone Replacement Therapy

For those with permanent pituitary damage, hormone replacement can restore normal function. Men typically receive testosterone replacement, while women may need estrogen and progesterone. If fertility is desired, specialized treatments like gonadotropin injections (FSH and LH) or pulsatile GnRH therapy may be necessary.

Treating Underlying Conditions

Prolactinomas often respond well to dopamine agonist medications like cabergoline or bromocriptine. Non-functioning tumors may require surgery or radiation if they're causing compression symptoms. Addressing lifestyle factors like stress, weight extremes, or excessive exercise can restore normal FSH production in functional cases.

When to Seek Medical Attention

You should consult a healthcare provider if you experience symptoms of low FSH or hormonal imbalance, particularly if they persist or worsen. Red flags that warrant immediate attention include severe headaches, vision changes, or sudden onset of multiple hormone deficiency symptoms, as these could indicate a rapidly growing pituitary tumor or apoplexy.

Early detection and treatment of pituitary disorders can prevent complications and improve quality of life. Regular monitoring of hormone levels, especially if you have risk factors or symptoms, enables timely intervention and optimal health outcomes.

Living with Low FSH: Management and Monitoring

Managing low FSH requires ongoing monitoring and adjustment of treatment. Regular follow-up appointments should include hormone level checks, assessment of symptoms, and monitoring for treatment side effects. For those on hormone replacement, levels typically need checking every 3-6 months initially, then annually once stable.

Lifestyle modifications can support hormonal health regardless of the underlying cause. Maintaining a healthy weight, managing stress through techniques like meditation or yoga, ensuring adequate sleep, and eating a balanced diet rich in nutrients all support optimal hormone production. Regular exercise, while beneficial, should be moderate rather than excessive.

The Bottom Line on Low FSH and Pituitary Health

While low FSH can indeed indicate a pituitary problem, it's not the only possible explanation. A thorough evaluation including comprehensive hormone testing, imaging when indicated, and consideration of all potential causes is essential for accurate diagnosis. Whether the cause is pituitary-related or stems from other factors, appropriate treatment can effectively manage symptoms and prevent complications.

Understanding your hormone levels and how they interconnect provides valuable insights into your overall health. If you suspect you have low FSH or are experiencing related symptoms, don't hesitate to seek medical evaluation. With proper diagnosis and treatment, most people with low FSH can achieve symptom relief and maintain good quality of life.

References

  1. Melmed, S., Casanueva, F. F., Hoffman, A. R., Kleinberg, D. L., Montori, V. M., Schlechte, J. A., & Wass, J. A. (2011). Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 96(2), 273-288.[PubMed][DOI]
  2. Bhasin, S., Brito, J. P., Cunningham, G. R., Hayes, F. J., Hodis, H. N., Matsumoto, A. M., ... & Yialamas, M. A. (2018). Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 103(5), 1715-1744.[PubMed][DOI]
  3. Gordon, C. M., Ackerman, K. E., Berga, S. L., Kaplan, J. R., Mastorakos, G., Misra, M., ... & Warren, M. P. (2017). Functional hypothalamic amenorrhea: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 102(5), 1413-1439.[PubMed][DOI]
  4. Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016). Hormonal replacement in hypopituitarism in adults: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 101(11), 3888-3921.[PubMed][DOI]
  5. Molitch, M. E. (2017). Diagnosis and treatment of pituitary adenomas: a review. JAMA, 317(5), 516-524.[PubMed][DOI]
  6. Young, J., Xu, C., Papadakis, G. E., Acierno, J. S., Maione, L., Hietamäki, J., ... & Pitteloud, N. (2019). Clinical management of congenital hypogonadotropic hypogonadism. Endocrine Reviews, 40(2), 669-710.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my FSH at home?

You can test your FSH at home with SiPhox Health's Hormone Focus Program, which includes FSH testing along with other key reproductive hormones like LH, sex hormones, and prolactin. This CLIA-certified program provides lab-quality results from the comfort of your home.

What is the normal FSH range for adults?

Normal FSH ranges vary by sex and menstrual phase. For men, normal is 1.5-12.4 mIU/mL. For women: follicular phase 1.4-9.9 mIU/mL, ovulation 6.2-17.2 mIU/mL, luteal phase 1.1-9.2 mIU/mL, and post-menopause 19.3-100.6 mIU/mL.

Can low FSH be reversed?

Yes, in many cases low FSH can be reversed by treating the underlying cause. Lifestyle-related suppression often resolves with stress reduction, weight normalization, or stopping causative medications. Pituitary tumors may respond to medication or surgery. However, some pituitary damage may be permanent and require ongoing hormone replacement.

What other tests should be done with FSH?

FSH should be tested alongside LH, testosterone (men) or estradiol (women), and prolactin to properly evaluate pituitary function. Additional tests may include TSH, free T4, cortisol, and IGF-1 to assess overall pituitary health. An MRI may be needed if pituitary dysfunction is suspected.

How long does it take for FSH levels to normalize after treatment?

Recovery time varies by cause. Lifestyle-related suppression may improve within 2-3 months of addressing the issue. After stopping hormonal medications, FSH can take 3-6 months to normalize. Prolactinoma treatment often shows improvement within weeks. Regular monitoring every 3 months helps track progress.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details